Video & Transcript Research : 'FDA'
Page 3 of 61
OK
Oklahoma 2026 Regular Session
Public Health REVISION 2- HB1912 - Added - Part 2 Feb 18th, 2026 at 10:10 am
Public Health
Bills:
HB4336, HB1818, HB3194, HB3538, HB3682, HB3762, HB3793, HB3930, HB3931, HB3934, HB4124, HB4200, HB4410, HB4457, HB4473, HB3884, HB1912
Keywords:
interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation, spinal cord stimulator, intrathecal infusion pump, endoscopic diskectomy, fluoroscopy, physician supervision, allopathic physician, osteopathic physician, CRNA, certified registered nurse anesthetist, nurse anesthetist, freestanding pain management facility, medical licensure
OK
Bills:
HB4336, HB1818, HB3194, HB3538, HB3682, HB3762, HB3793, HB3930, HB3931, HB3934, HB4124, HB4200, HB4410, HB4457, HB4473, HB3884, HB1912
Keywords:
interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation, spinal cord stimulator, intrathecal infusion pump, endoscopic diskectomy, fluoroscopy, physician supervision, allopathic physician, osteopathic physician, CRNA, certified registered nurse anesthetist, nurse anesthetist, freestanding pain management facility, medical licensure
TX
Transcript Highlights:
- States can allow pharmacists to dispense the drug without FDA approval, but FDA approval would be required
- I mean, I know the FDA decides a lot of that, but does DSA?
- It is an FDA determination and the medication we're talking about here is... is per the FDA considered
- So Fauci at the FDA or had the FDA declare it. a veterinary medicine only, and encouraged American people
- And that requires FDA approval. Right. FDA approval to have Tylenol on the shelf. Yes.
Bills:
HB5141, HB4638, HB2264, HB2035, HB4813, HB4408, HB2684, HB1621, HB2300, HB216, HB3829, HB4466, HB1747, HB2284, HB3614, HB2587, HB3219, HB3318, HB5147, HB4014, HB216
Keywords:
lease, state property, public purpose, Travis County, Health and Human Services, pharmaceutical initiative, drug distribution, healthcare services, generic drugs, advanced pharmaceuticals, cost savings, mental health, patient discharge, medical records, health care professionals, substance use, family involvement, chemical dependency, treatment facilities, minor admissions
TX
Transcript Highlights:
- FDA approval has been granted to U.S.
- Despite FDA approval, there are safety concerns.
- I want to remind this committee that the FDA approval we're talking about is not the FDA approval that
- Not just the FDA.
- use a lot of medicine approved by the FDA.
Bills:
HB 44, HB 2200, HB 1612, HB 2747, HB 2038, HB 3717, HB 1431, HB 3800, HB 3801, HB 3560, HB 3246
Keywords:
HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care
Summary:
The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.
AZ
Arizona 2026 Regular Session
01/06/2026 - Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies
Transcript Highlights:
- , and some of these have even received breakthrough therapy designation by the FDA.
- They're sponsored by drug developers who are seeking FDA approval.
- FDA to treat 24.
- approval. ...and reduce suffering now, not wait 20 years for FDA approval.
- Support among lots of key people at HHS, VA, and FDA.
Summary:
The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place.
Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur.
Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.
US
US Federal 2025-2026 Regular Session
Hearings to examine biomedical research, focusing on keeping America's edge in innovation. Apr 30th, 2025 at 09:30 am
Senate Appropriations
Transcript Highlights:
- For example, over the past 20 years, the FDA has approved more than 600 new cancer treatments, including
- And while we're talking about government efficiency, let's not forget the FDA, which families trust to
- Esham, the Executive Director from the Alliance for a Stronger FDA.
- The FDA is doing clinical trials. So you've got a lot going that comes together.
- Last year, I asked former FDA Commissioner Dr.
AL
Transcript Highlights:
- So, this legislation is duplicative of long-standing FDA policy.
- duplicative of long-standing FDA policy. duplicative of long-standing FDA policy.
- definition for the term natural, FDA definition for the term natural, FDA does<00:18:07.840>
- I also think that under the new FDA.
- <00:22:48.159>
definition following that that FDA definition following that that FDA definition
Keywords:
HB139, Alabama discrimination, civil rights, public accommodations, employment discrimination, equal access, protected classes, race discrimination, sex discrimination, religious discrimination, age discrimination, disability discrimination, national origin discrimination, school board discrimination, labor organization, employment agency, retaliation, private right of action, punitive damages, attorney fees
CA
California 2025-2026 Regular Session
Senate Business, Professions and Economic Development Committee Jun 29th, 2026
Business, Professions and Economic Development
Transcript Highlights:
- And you're saying in order to advertise, you need FDA approval, but they don't do FDA approval on these
- Compounded drugs are not FDA-approved.
- drugs need to put the entire FDA-approved label even in an ad.
- But this bill does not require FDA approval. No, not at all, sir.
- They're not FDA-approved.
NH
New Hampshire 2026 Regular Session
House Special Committee on COVID Response Efficacy (06/05/2026)
Transcript Highlights:
- Dumel's data analysis to senior FDA Dumel's data analysis to senior FDA officials.<00:52:09.359>
- Sarsman, who was a in FDA, that Dr.
- of data as clearly seen in the CDC FDA. of data as clearly seen in the CDC FDA.
- It comes from FDA and CDC itself.
- It comes from FDA and CDC itself.
Summary:
The New Hampshire House Special Committee on the COVID Response Efficacy met to continue its fact-finding review of the state’s pandemic response, with the chair restating the committee’s mission and focus on federal guidance, federal funding, emergency use authorization vaccination efforts, long COVID, patient rights, and vaccination policies. The chair said the committee had previously reviewed materials about the U.S. Supreme Court declining to hear a COVID vaccine case and CDC internal emails about vaccine risks, and introduced additional research on CDC testing and communications failures.
A large portion of the meeting was devoted to summarizing articles and a recent U.S. Senate Permanent Subcommittee on Investigations report titled *Unmasked: How Biden Health Officials Purposely Turned a Blind Eye Toward COVID-19 Vaccine Safety Signals*. The chair argued that CDC testing and guidance were flawed, citing delayed data publication, confusing guidance, a faulty early COVID test, missed opportunities to study silent spread, and alleged suppression of safety information. The Senate report was described as alleging that FDA and CDC officials knew their surveillance systems could mask vaccine safety signals, that officials discouraged internal analysis from being shared externally, and that newer analytical methods identified multiple statistically significant adverse-event signals. The chair also discussed the V-safe system, VAERS, and claims that federal officials downplayed or concealed adverse-event data.
Members and the chair connected these federal issues to New Hampshire, noting changes in the state’s health care landscape since the pandemic, including more urgent care facilities and satellite ERs. The chair suggested New Hampshire should develop independent scientific assessment resources to validate federal information in future emergencies. Representative Wheeler noted that the materials would be entered into the committee record and made available on the House website. No votes were taken; the committee discussed the materials, invited further questions, and indicated that a proposed committee communication would be revisited later after additional supporting information is gathered, with a goal of issuing a statement by the end of June.
FL
Transcript Highlights:
- Where is the FDA on prohibiting the other eight products?
- I know that there are people talking to the FDA about these other chemicals.
- We have no doubt that this is a very serious undertaking by the new secretary and the FDA.
- So every state becomes a de facto FDA.
- Thank you for your comments. every state becomes a de facto FDA.
Summary:
The Committee on Agriculture met with a quorum present and heard four bills. CS/SB 150, by Senator Gates, would make it a third-degree felony to abandon a restrained animal during a declared weather emergency, such as a hurricane or tornado, and was presented as “Trooper’s Law” in response to a widely publicized rescue of a dog during Hurricane Milton. The bill drew supportive public cards and brief supportive remarks from Senator Boyd, then passed unanimously and was reported favorably.
SB 374, by Senator Truenow, would refine the definition of farm product to include plant and plant products and bar local governments from adopting ordinances that limit the collection, storage, and processing of farm products on bona fide agricultural land. An amendment was withdrawn to allow further discussion on food waste issues. Speakers from composting, recycling, and poultry interests supported the bill, and it was reported favorably.
SB 560, by Senator Martin, would restrict certain chemical additives in food products. The sponsor said the bill targets 10 chemicals he believes are harmful, noted that two have already been banned by the FDA, and argued Florida should act rather than wait for federal action. Industry and retail witnesses opposed the bill as creating a patchwork of state rules, raising costs, and disrupting supply chains, while some senators said they supported the bill for now but expected further changes. The committee reported the bill favorably, with Senator Rouson voting no.
SB 572, the Pam Rock Act by Senator Collins, would create a statewide dangerous dog registry, add criminal penalties for certain dangerous-dog attacks, and require permits, microchipping, spay/neuter, and $100,000 liability insurance for dangerous dogs. The sponsor and the Rock family described severe attacks and deaths involving dangerous dogs and argued the registry would help protect the public. Some senators questioned the registry’s usefulness, the amount of information collected, and insurance availability, but the bill passed and was reported favorably. The committee then adjourned.
TX
Transcript Highlights:
- But you said it's FDA approved. In what context is it FDA approved for prescription? Yes. Okay.
- The FDA asks what they believe it should be used for, and then the FDA says, "Show us the proof," and
- The FDA has not approved this for COVID-19 use.
- Once the federal agency, FDA, has determined.
- But the FDA does have adverse...
Keywords:
youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting, child neglect, mandatory reporting, background check, criminal history check, sex offender registry, CPR training, first aid, public health, child protection, camp operator, camp counselor, Health and Safety Code
NH
New Hampshire 2026 Regular Session
Senate Health and Human Services (04/01/2026)
Health and Human Services
Transcript Highlights:
- FDA-approved treatment plan.
- The FDA just We already have that.
- does not have a FDA approved equivalent. does not have a FDA approved equivalent.
- But I don't think the focus for FDA and in my organization's mind is FDA and in my organization's mind
- Joshua Berg. if it's past FDA one, it's safe. So, if it's past FDA one, it's safe.
CA
Transcript Highlights:
- I see lots of advertisement on the non-FDA-regulated vitamin kind of, as they say...
- I think that it's probably enforced by the FDA.
- Just at FDA, I have to make a complaint or an inquiry to the FDA if I have certain questions or not on
- It's the only FDA-approved form of vitamin B12.
- The FDA reviewed hundreds of non-FDA-approved bulk drug substances used in compounding, and they classified
Summary:
The joint Assembly and Senate business committees held a sunset review hearing on the California State Board of Pharmacy, with board leadership describing the board’s consumer-protection role and its priorities around access, enforcement, and updating pharmacy law. The board emphasized a proposed shift toward a standard-of-care model for pharmacists, arguing it would reduce rigid protocol requirements and improve access to services such as HIV PrEP/PEP, contraception, and naloxone. Board representatives also discussed pharmacy deserts, possible fee waivers for pharmacies in underserved areas, concerns about payer practices contributing to closures, continuing education audits, and a request to restore more flexibility in licensure decisions and probationary monitoring for applicants with certain criminal histories.
A major focus of the hearing was the board’s ongoing compounding regulations, especially the treatment of sterile versus nonsterile compounding and substances such as glutathione and methylcobalamin. The board said the proposal was not a ban on those substances and described the rulemaking as grounded in federal law, USP standards, and public comment, noting the process had gone through multiple modified texts and hearings. Testimony from stakeholders was sharply divided: pharmacists, veterinarians, firefighters, naturopathic doctors, and patient advocates warned the rules were restricting access to compounded medications and harming patients and first responders, while the California Medical Association, psychiatric physicians, and PhRMA raised concerns that the board’s proposals could expand pharmacist authority beyond training, affect physician practice, or create safety risks. Other public comments addressed pharmacy technician ratios, remote processing, flavoring medications, hospital-specific regulation, budget and enforcement transparency, and whether the board should add members with community compounding or pharmacy technician expertise.
Committee members also asked about the board’s oversight priorities and the rationale for its standard-of-care proposal. Board staff explained that consumer protection includes education, licensing, policy, and enforcement, with the highest-priority enforcement cases being those posing imminent public harm. After public testimony concluded, the chairs thanked participants and adjourned the sunset review hearing, announcing an immediate transition to the joint informational hearing on the Department of Cannabis Control.
KY
Kentucky 2026 Regular Session
House Standing Committee on Veterans, Military Affairs, and Public Protection (3-24-26)
Veterans, Military Affairs, & Public Protection
Transcript Highlights:
- I also have experience with the<00:05:55.600>
FDA. the FDA. the FDA. - to fund FDA approval for ibogaine. to fund FDA approval for ibogaine.
- The estimated total cost for FDA The estimated total cost for FDA approval<00:09:37.600>
is <00:10:26.480>- Ibogaine,
Kentucky Once the FDA approves Ibogaine, Kentucky Once the FDA approves - Ibogaine is approved by the FDA. Ibogaine is approved by the FDA.
FL
Florida 2026 5th Special Session
Regulated Industries Jan 27th, 2026
Transcript Highlights:
- would not apply to nicotine dispensing devices that have received marketing authorization from the FDA
- So they are being sold today without FDA approval in convenience stores, in... ...they are being sold
- today without FDA approval in convenience stores, in gas stations, across the country, et cetera, et
- There is not federal or state enforcement dollars to engage with us, nor has there been FDA... ...to
- approved—and I like the idea of... ...they themselves are not FDA approved.
Summary:
The Committee on Regulated Industries met and reported several bills favorably. SB 530 on state lotteries was presented with two technical amendments and passed as amended. The bill revises Department of Lottery powers and duties, updates bid/proposal information requirements, adds definitions related to ball machines, and gives the department more flexibility to purchase rather than lease machines. SB 204 also passed favorably; it increases penalties for illegal slot machine operations to a third-degree felony and creates a process for veteran service organizations to seek binding declaratory statements from the Gaming Commission about whether a machine is lawful. Testimony on SB 204 included support from Florida Gaming and soft opposition from a veteran organization that wanted clearer language and more cooperation on electronic bingo-type games.
The committee then took up a combined proposed committee substitute merging SB 658 and SB 608 on water safety requirements for rental and residential properties. The merged bill requires certain rental properties near water bodies or with swimming pools to have specified safety devices, such as exit alarms, self-closing/self-latching locks, pool fences, pool covers, or pool alarms, and allows DBPR enforcement for vacation rentals. Supporters emphasized the bill’s goal of preventing child drownings, citing Florida’s high number of fatal drownings and the disproportionate impact on young children and children with autism. The combined bill was reported favorably.
SB 980 on nicotine dispensing devices was amended with a delete-all amendment creating the Florida Agegate Act. The substitute bill restricts advertising, promotion, and display of non-FDA-approved nicotine devices in retail settings accessible to those under 21, sets escalating penalties, directs fine revenue to enforcement and youth prevention, and authorizes inspections and warrantless searches tied to retail permits. Members discussed whether the bill would effectively curb illegal and counterfeit products and how enforcement would work; the sponsor said the measure is intended to reduce youth access in light of limited enforcement resources. The bill passed favorably. SB 1708 on veterinary licensure by endorsement also passed, removing a three-year out-of-state practice requirement for licensed veterinarians while keeping other qualifications intact to help address veterinary shortages. Finally, SB 680 on electric vehicle charging taxation passed with a strike-all amendment creating a sales tax exemption for electricity sold to EV charging station operators and transferred to consumers, provided it is separately metered and properly documented. The committee adjourned after noting additional support forms and inviting members to a later K-12 speech and debate bill presentation.
TX
Texas 89th 2nd C.S.
S/C on Disease Prevention & Women's & Children's Health Mar 20th, 2025
S/C on Disease Prevention & Women's & Children's Health
Transcript Highlights:
- The FDA already regulates this. That's a fallacy. They do not regulate this.
- What the FDA is telling us at this point.
- I mean, our country, if we have problems with the FDA, let's fix the process of the FDA.
- You were talking about the FDA moving this to 2029.
- Um, one timely example is the recent FDA ban of the food coloring red 3.
FL
Florida 2026 5th Special Session
Agriculture Mar 3rd, 2025
Transcript Highlights:
- Where is the FDA on prohibiting the other eight products?
- Where is the FDA on prohibiting the other eight products?
- I know that there are people talking to the FDA about these other chemicals.
- We have no..." "...continuing to work with the FDA as they dig into this.
- Every state becomes a de facto FDA.
Summary:
The Committee on Agriculture met with a quorum present and took up four bills. First, CS/SB 150, “Trooper’s Law,” by Senator Gates, would make it a third-degree felony to abandon or restrain an animal during a declared weather emergency, such as a hurricane or tornado. The bill was presented as a response to a widely publicized case of a dog tied to a fence during Hurricane Milton. Several speakers supported the measure, and the committee voted unanimously to report it favorably.
Next, SB 374 by Senator Trunow would refine the definition of “farm product” to include plant and plant products and bar local governments from restricting the collection, storage, and processing of farm products on bona fide agricultural land. An amendment related to food waste was withdrawn for further discussion, and public testimony came from composting, recycling, and poultry interests in support. The bill was then reported favorably. The committee also heard SB 560 by Senator Martin on chemical additives in food products, which would restrict a list of 10 chemicals in food. The sponsor argued the bill was aimed at serious health concerns and noted some chemicals had already been banned federally; industry and retail witnesses opposed the bill as creating a patchwork of state rules and potential market disruptions, while some senators supported the health goal but raised concerns about consistency. The committee voted to report SB 560 favorably, with one recorded no vote.
Finally, SB 572, the Pam Rock Act by Senator Collins, would create a statewide dangerous dog registry and impose additional criminal penalties, permitting requirements, microchipping, sterilization, and insurance requirements for dangerous dogs. The sponsor and family members of attack victims described severe injuries and deaths to support the need for public notice and accountability. Some members questioned the usefulness of a registry and the burden of the information requirements, but the sponsor said the bill was intended to prevent repeat attacks and help victims. The committee voted to report SB 572 favorably. The meeting then adjourned.
CA
California 2025-2026 Regular Session
Assembly Environmental Safety and Toxic Materials Committee Mar 25th, 2025
Environmental Safety and Toxic Materials
Transcript Highlights:
- Three chemicals that I struggle to pronounce, but understandably the FDA has a lot of concerns about
- FDA has set the standards for success different between the health care and consumer products.
- So for the health care products, FDA has required that we use clinical simulation studies.
- In terms of the agricultural setting, so FDA agreed that there should be three monographs.
- FDA has not yet taken that back up. So we are due a food handler monograph.
TX
Transcript Highlights:
- You said it's FDA approved. In, in what context is it FDA approved for prescription? Yes.
- I, I The FDA has not approved this for COVID-19 use.
- This is, and this is an approved, it's FDA approved medicine.
- It was FDA approved.
- I, I would imagine that has to do with FDA as well.
Keywords:
youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting, child neglect, mandatory reporting, background check, criminal history check, sex offender registry, CPR training, first aid, public health, child protection, camp operator, camp counselor, Health and Safety Code
NV
Nevada 2025 Regular Session
Assembly Committee on Ways and Means May 31st, 2025 at 09:00 am
Ways and Means
Transcript Highlights:
- Currently, many vapor products in the Nevada market are in violation of FDA rules.
- I deal with the FDA directly, and the FDA sent us a letter in 2023.
- FDA directly, and the FDA sent us a letter in 2023 regarding a product that they wanted removed from
- The FDA was just in my store this April, about six weeks ago. I've seen the FDA in my store more...
- The FDA does enforcement.
Bills:
AB568, SB90, SB133, SB147, SB229, SB233, SB240, SB245, SB280, SB378, SB393, SB417, SB434, SB494, SB495, AB62, SB104, SB119, SB132, SB193, SB262, SB422, SB431, SB435, SB468, SB503
Keywords:
higher education, Nevada System of Higher Education, operational expenses, instructional expenses, public funding, education funding, teacher grants, classroom supplies, instructional support, specialized personnel, civics education, Nevada Center for Civic Engagement, funding, youth programs, civic involvement, Southern Nevada, Clark County, Las Vegas Valley, regional planning, economic resiliency